Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 19
213
Views
9
CrossRef citations to date
0
Altmetric
Short Communications

A new triterpenoid and other constituents with cytotoxic activity from the roots of Sanguisorba officinalis L

, , , , , , & show all
Pages 3341-3345 | Received 01 Aug 2019, Accepted 06 Nov 2019, Published online: 04 Dec 2019
 

Abstract

Sanguisorba officinalis L. is a traditional herbal plant that belongs to the genus Sanguisorba and the family Rosaceae. A new ursane-type triterpenoid, 3-oxo-urs-11, 13(18)-dien-19, 28-olide (1), two known ursane-type triterpenoids (3  4) and three known oleanane-type triterpenoids (2, 5  6) were isolated from the roots of S. officinalis by silica gel column and MPLC. Their structures were identified by interpretation of spectroscopic data (1 D NMR, 2 D NMR, HR-ESI-MS) and comparison with those reported in the literature. Compound 2 was isolated from the Rosaceae family, compounds 35 were obtained from the genus Sanguisorba, and compound 6 was obtained from the S. officinalis for the first time. Additionally, all of the isolated compounds were evaluated for their cytotoxic activity against three human cancer cells. Compound 3 showed better cytotoxic activity against A549, HeLa, SK-Hep1 cells than the other compounds with IC50 values of 48.58 ± 1.88, 47.84 ± 2.01, 42.31 ± 2.43 μM, respectively.

Graphical Abstract

Disclosure statement

The authors declare that they have no conflict of interest.

Additional information

Funding

This research was supported by the National Natural Science Foundation of China (No. 81760627, 81660699, and 81660579). We thank Louise Adam, ELS(D), from Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac. . . . . . . . . . ) for editing the English text of a draft of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.